Skip to main content

Table 1 Baseline characteristics

From: Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

 

Overall

FGF-23 < median

FGF-23 > median

P value

n = 182

n = 91

n = 91

Age (years)

71 (58;79)

67 (54;75)

74 (63;81)

<0.001

Male sex, n (%)

126 (69)

71 (78)

55 (60)

0.02

Body mass index (kg/m2)

27.3 (24.5;29.4)

27.5 (24.7;29.7)

27.1 (24.5;29.4)

0.49

Baseline serum creatinine (μmol/L)

117 (95;163)

99 (81;123)

147 (109;208)

<0.001

Baseline serum lactate (mmol/L)

3.7 (2.3;7.1)

3.0 (2.0;5.5)

4.6 (3.1;7.8)

<0.001

Baseline troponin T (μg/L)

0.9 (0.3;2.9)

0.7 (0.2;1.6)

1.2 (0.4;3.4)

0.01

Heart rate at admission (n/min)

91 (75;110)

90 (72;110)

98 (78;114)

0.16

Systolic blood pressure at admission (mmHg)

86 (78;106)

85 (79;105)

86 (78;106)

0.98

Hypertension, n (%)

127 (70)

57 (63)

70 (77)

0.053

Hypercholesterolemia, n (%)

55 (30)

22 (24)

33 (36)

0.11

Diabetes mellitus, n (%)

65 (36)

28 (31)

37 (41)

0.22

Known peripheral artery disease, n (%)

22 (12)

5 (5)

17 (19)

0.01

Prior myocardial infarction, n (%)

39 (21)

20 (22)

19 (21)

0.99

Prior PCI, n (%)

33 (18)

17 (19)

16 (18)

0.99

Prior CABG, n (%)

10 (6)

6 (7)

4 (4)

0.75

Randomized to IABP, n (%)

89 (49)

51 (56)

38 (42)

0.08

Triple-vessel disease, n (%)

90 (50)

33 (36)

57 (63)

<0.001

Resuscitation, n (%)

67 (37)

38 (42)

29 (32)

0.22

Mechanical ventilation at admission, n (%)

95 (52)

45 (49)

50 (55)

0.55

  1. FGF-23: fibroblast growth factor-23; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; IABP: intraaortic balloon pump.